The Impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000nab a2200000 i 4500</leader>
    <controlfield tag="001">MAP20071504938</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20080418124434.0</controlfield>
    <controlfield tag="007">hzruuu---uuuu</controlfield>
    <controlfield tag="008">040218e20031201usa||||    | |00010|eng d</controlfield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">873</subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="4">
      <subfield code="a">The Impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome</subfield>
      <subfield code="c">John C. Lipscomb ... [et al.]</subfield>
    </datafield>
    <datafield tag="520" ind1="8" ind2=" ">
      <subfield code="a">Risk assessment include assumptions about sensitive subpopulations, such as the fraction of the general population that is sensitive and the extent that biochemical or physiological attributes influence sensitivity. Uncertainty factor account for both pharmacokinetic (PK) and pharmacodynamic (PD) components, allowing the inclusin of risk-relevant information to replace default assumptions about PK and PD variance (uncertainty)</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080575083</subfield>
      <subfield code="a">Citrocromo P-450</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080537043</subfield>
      <subfield code="a">TCP</subfield>
    </datafield>
    <datafield tag="650" ind1="0" ind2="1">
      <subfield code="0">MAPA20080576615</subfield>
      <subfield code="a">Medicina laboral</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080565541</subfield>
      <subfield code="a">Epidemiología</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080577155</subfield>
      <subfield code="a">Plantas químicas</subfield>
    </datafield>
    <datafield tag="650" ind1="0" ind2="1">
      <subfield code="0">MAPA20080570484</subfield>
      <subfield code="a">Riesgo laboral</subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20080198640</subfield>
      <subfield code="a">Lipscomb, John C.</subfield>
    </datafield>
    <datafield tag="773" ind1="0" ind2=" ">
      <subfield code="w">MAP20077000345</subfield>
      <subfield code="t">Risk analysis : an international journal</subfield>
      <subfield code="d">New York and London : Society for Risk Analysis</subfield>
      <subfield code="g">Vol. 23, nº 6, December, 2003 ; p. 1221-1238</subfield>
    </datafield>
  </record>
</collection>